Similar Posts
Tigress Financial Partners Fined by FINRA
Tigress Financial Partners has been fined $100,000 by FINRA after the regulator found deficiencies in its anti-money laundering (AML) compliance programme and failures to disclose required information on customer trade confirmations. According to FINRA’s disciplinary notice, posted on Thursday, Tigress onboarded hundreds of high-risk foreign customers between 2018 and 2022, but failed to implement adequate…
European Union fires back, euro gains ground – MarketPulse
The euro has gained ground on Tuesday. In the North American session, EUR/USD is trading at 1.0485, up 0.18%. On Monday, the euro climbed as high as 1.0527, its highest level this year. EU says will retaliate if US imposes tariffs US President Donald Trump tariff threat has many countries up in arms, including staunch…
Dow Jones –31.01.2025 – Orbex Forex Trading Blog
Dow Jones –31.01.2025 – Orbex Forex Trading Blog XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX” width=”0″ style=”display:none;visibility:hidden”> Source link
World Bank says risks to India’s projected 6.6% growth in FY27 skewed to downside
World Bank says risks to India’s projected 6.6% growth in FY27 skewed to downside Source link
Centroid Solutions integrates with Bloomberg FixNet – e-Forex
Centroid solutions has announced that its Centroid Bridge is now integrated with …. Centroid solutions has announced that its Centroid Bridge is now integrated with Bloomberg FixNet. This integration enhances Centroid’s connectivity solutions, enabling brokers to seamlessly connect with other brokers from Bloomberg’s FixNet across all continents. Bloomberg FixNet hosts one of the largest private…
BioAge Plunges Over 60% â What’s Weighing Down The STRIDES Trial Of Its Obesity Drug?
Shares of BioAge Labs Inc. (BIOA) experienced a dramatic decline of over 60% in after-hours trading on Friday, following the company’s announcement to cease the ongoing STRIDES trial.The STRIDES trial, a phase II study, was evaluating BioAge’s lead drug candidate, Azelaprag, in conjunction with Eli Lilly’s weight management medication, tirzepatide, for the treatment of obesity.The…
